Back to compounds

COMPOUND PROFILE / PEPTIDES & ANALOGUES

HNG / S14G-Humanin.

Research draft

HNG, also called S14G-Humanin, is a modified Humanin analogue.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

HNG, also called S14G-Humanin, is a modified Humanin analogue.

CLASSIFICATIONPeptides & analogues
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

The substitution alters experimental activity in cell-survival pathways.

Human research

Native Humanin biomarker observations cannot establish HNG treatment benefit.

Preclinical & other research

Cell and animal studies investigated amyloid toxicity and platelet responses.

Safety & unknowns

Therapeutic human exposure and long-term safety are not established.

Regulatory status

Preclinical candidate, distinct from native Humanin.

Reported use & evidence

Research profile draft

The supplied HNG / S14G-Humanin profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds